The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS

Pharmacotherapy

Volumn 16, Issue 3 I, 1996, Pages 393-400

  Mertl, Sue Lyon ^a  

^a Lyon Consulting Group Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZITHROMYCIN; CD4 ANTIGEN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; DAPSONE; ETHAMBUTOL; GENTAMICIN; PENTAMIDINE; PYRIMETHAMINE; RIFABUTIN; RIFAMPICIN; SPARFLOXACIN; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; META ANALYSIS; MULTICENTER STUDY; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NEUTROPENIA; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; SPUTUM CULTURE; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; HUMANS; MYCOBACTERIUM AVIUM COMPLEX;

EID: 0029898359     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Benson CA. Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS. Clin Infect Dis 1994;18(suppl 3):S237-42.
2. Lane HC, Laughton BE, Fallon J, el al. Recent advances in the management of AIDS-relaled opportunistic infections. Ann Intern Med 1994;120:945-55.
3. Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324(19):1332-8.
4. Greene JB, Sidhu GS, Lewin S, et al. Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infections in homosexuals and drug abusers. Ann Intern Med 1982;97:539-46.
5. Zakowski P, Fligiel S, Berlin OGW, Johnson L Jr. Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency. JAMA 1982;248(22):2980-2.
6. Horsburgh CR Jr, Mason UG III, Farhi DC, Iseman MD. Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. Medicine 1985;64:36-48.
7. Wong B, Edwards FF, Kiehn TE, et al. Continuous high-grade Mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am J Med 1985;78:35-40.
8. Hawkins CC, Gold JWM, Whimbey F, et al. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986;105: 184-8.
9. Masur H, Tuazon C, Gill V, et al. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. J Infect Dis 1987:155:127-9.
10. Wallace JM, Hannah JB. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study. Chest 1988;93(5):926-32.
11. Agins BD, Berman DS, Spicehandler D, El-Sadr W, Simberkoff MS, Rahal JJ. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. J Infect Dis 1989;159:784-7.
12. Guthertz LS, Damsker B, Bottone EJ, Ford EG, Midura TF, Janda JM. Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis 1989;160(6):1037-41.
13. Hoy J, Mijch A, Sandland M, Grayson L, Lucas R, Dwyer B. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacleremia in AIDS patients. J Infect Dis 1990;161:801-5.
14. Ellner JJ, Goldberger MJ, Parenti DM. Mycobacterium avium infection and AIDS:a therapeutic dilemma in rapid evolution. J Infect Dis 1991;163:1326-35.
15. Horsburgh CR Jr, Havlik JA, Ellis EA, et al. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis 1991;144:557-9.
16. Cohn D, Horsburgh CR Jr. Treatment and prophylaxis of disseminated Mycobacterium avium complex infection in AIDS. Opportunistic Complications of HIV 1993;2(1):6-12.
17. Dautzenberg B, Truffot C, Legris S, et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome:a controlled clinical trial. Am Rev Respir Dis 1991;144:564-9.
18. Young LS, Wiviott L, Wu M, Kolonoski P, Bolan R, Inderlied CB. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 1991;338:1107-9.
19. Chaisson RE, Benson C, Dube M, et al. Clarithromycin therapy for disseminated Mycobacterium avium complex (MAC) in AIDS [abstr 891]. In:Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11-14, 1992. Washington, DC:American Society for Microbiology, 1992.
20. Gupta S, Blahunka K, Dellerson M, Craft JC, Smith T. Interim results of safety and efficacy of clarithromycin (C) in the treatment of disseminated Mycobacterium avium complex (MAC) infection in patients (Pts) with AIDS [abstr 892]. In:Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11-14, 1992. Washington, DC:American Society for Microbiology, 1992.
21. Kemper C, Havlir D, Haghighat D, et al. Effect of ethambutol, rifampin, or clofazimine, given singly, on Mycobacterium avium bacteremia in AIDS. In:Programs and abstracts of the 8th International Conference on AIDS. Amsterdam, July 19-24, 1992. Washington, DC:International AIDS Society/World Health Organization, 1992.
22. Nightingale S, Saletan S, Swenson C, et al. Phase I/II study of TLC G-65 (liposome-encapsulated gentamicin) for treatment of Mycobacterium avium-complex (MAC) disease labstr 898]. In:Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11-14, 1992. Washington, DC:American Society for Microbiology, 1992.
23. Young LS, Wu M, Bender J. Pilot study of sparfloxacin for M. avium complex MAC) bacteremia complicating AIDS [abstr 897]. In:Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11-14, 1992. Washington, DC:American Society for Microbiology, 1992.
24. Dautzenberg B, Saint Marc T, Meyohas MC, et al. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch Intern Med 1993;153:368-72.
25. Chiu J, Nussbaum J, Bozzelte S, et al. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann Intern Med 1990;113(5):358-61.
26. Benson C, Kessler HA, Pottage JC, Trenholme GM. Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. Arch Intern Med 1991;151:582-5.
27. Saint Marc T, Touraine JL. Clinical experience with a combination of clarithromycin and clofazimine in the treatment of disseminated M. avium infections in AIDS patients [abstr 237]. In:Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 29-October 2, 1991. Washington, DC:American Society for Microbiology, 1991.
28. Dautzenberg B, Hazebroucq J, Chauvin JP. Clarithromycin in 100 AIDS patients with disseminated M. avium infection [abstr 893]. In:Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Anaheim, CA:American Society for Microbiology, 1992.
29. Kemper C, Havlir D, Haghighat D, et al. Effect of ethambutol (EMB), rifampin (RIF), and clofazimine (CLO), in combinations of two, on M. avium bacteremia [abstr 894] In:Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11-14, 1992. Washington, DC:American Society for Microbiology, 1992.
30. Kemper CA, Meng T-C, Nussbaum J, et al. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen:rifampin, ethambutol, clofazimine, and ciprofloxacin. Ann Intern Med 1992;116(6):466-72.
31. de Lalla F, Maserati R, Scarpellini P, et al. Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. Antimicrob Agents Chemother 1992;36(7):1567-9.
32. Jacobson MA, Yajko D, Northfelt D, et al. Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection. J Infect Dis 1993;168:112-19
33. Masur H, and the Public Health Service Task Force on Prophylaxis and Treatment for MAC. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. N Engl J Med 1993;329:898-904.
34. Abbott Laboratories. Package insert, Biaxin (clarithromycin). Abbott Park, IL;December 1993.
35. Kemper CA, Havlir D, Haghighat D, et al. The individual microbiologic effect of three antimicrobial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. J Infect Dis 1994;170:157-64.
36. Benson CA, Ellner JJ. Mycobacterium avium complex infection and AIDS:advances in theory and practice. Clin Infect Dis 1993;17:7-20.
37. Gordin F, Masur H. Prophylaxis of Mycobacterium avium complex bacteremia in patients with AIDS. Clin Infect Dis 1994;18(suppl 3):S223-6.
38. Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 1994;120:932-44.
39. Maddix DS, Tallian KB, Mead PS. Rifabutin:a review with emphasis on its role in the prevention of disseminated Mycobacterium avium complex infection. Ann Pharmacother 1994;28:1250-4.
40. Pierce M, Lamarca A, Jablonowski H, et al. A placebocontrolled trial of clarithromycin prophylaxis against MAC infection in AIDS patients [abstr A/2]. In:Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4-7, 1994. Washington, DC:American Society for Microbiology, 1992.
41. Miller DA. Clarithromycin:Safe and effective prophylactic agent against MAC [abstr PB0720|. In:Program and abstracts of the 10th International Conference on AIDS, Yokohama, Japan, August 7-12, 1994. Washington, DC:International AIDS Society/World Health Organization, 1994:177.
42. Coulston DR, Wood CD. Clarithromycin for the prevention of Mycobacterium avium complex in patients with AIDS [abstr PB0557]. In:Program and abstracts of the 10th International Conference on AIDS, Yokohama, Japan, August 7-12, 1994. Washington, DC:International AIDS Society/World Health Organization, 1994:136.
43. Golden SW. Clarithromycin 500 mg twice/day for MAC prophylaxis in patients with AIDS [abstr PB0558], In:Program and abstracts of the 10th International Conference on AIDS, Yokohama, Japan, August 7-12, 1994. Washington, DC:International AIDS Society/World Health Organization, 1994:136.
44. Grossman HA. Clarithromycin 500 mg twice/day as primary MAC prophylaxis in patients with AIDS [abstr PB0559]. In:Program and abstracts of the 10th International Conference on AIDS, Yokohama japan, August 7-12, 1994. Washington, DC:International AIDS Society/World Health Organization, 1994:136.
45. Greiger-Zanlungo P, Alaie-Petrillo A. MAC prophylaxis:clarithromycin 500 mg twice/day in patients with AIDS [abstr PB0560]. In:Program and abstracts of the 10th International Conference on AIDS, Yokohama, Japan, August 7-12, 1994. Washington, DC:International AIDS Society/World Health Organization, 1994:137.
46. Grossman HA, Greiger-Zanlungo P, Sonnabend J, Senior S. Clarithromycin 500 mg twice/day as primary prophylaxis for dMAC disease [abstr 1191]. In:Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, October 4-7, 1994. Washington, DC:American Society for Microbiology, 1994.
47. Keith PE, Schiller TL. Clarithromycin as primary prophylaxis in patients with AIDS [abstr 1195]. In:Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4-7, 1994. Washington, DC:American Society for Microbiology, 1994.
48. Payne DL. A retrospective study of clarithromycin as primary prophylaxis for MAC disease [abstr 302]. In:Program and abstracts of the 2nd International Conference on the Macrolides, Azalides and Streptogramins, Venice, Italy, January 19-22, 1994. Princeton, NJ:Wallace Communications, 1994:68.
49. Sonnabend JA, Smith RP. Clarithromycin for Mycobacterium avium complex prophylaxis in AIDS [abstr 303]. In:Program and abstracts of the 2nd International Conference on the Macrolides, Azalides and Streptogramins. Venice, Italy, January 19-22, 1994. Princeton, NJ:Wallace Communications, 1994:68.
50. McIntyre K, Torres R, Barr M, George N, Shay W. Open study of clarithromycin for primary prevention of symptomatic Mycobacterium avium complex (MAC) disease [abstr PO-B07-1185]. In:Programs and abstracts of the IXth International Conference on AIDS/IVth STD World Congress, Berlin, Germany, June 6-11, 1993. Berlin:Institute for Clinical and Experimental Virology of the Free University of Berlin, 1993.
51. Illeman M, Poscher K, Conant K. Mycobacterium avium complex disease (MAC) prophylaxis with clarithromycin [abstr PO-B07-1234]. In:Program and abstracts of IXth International Conference on AIDS/IVth STD World Congress, Berlin, Germany, June 6-11, 1993. Berlin:Institute for Clinical and Experimental Virology of the Free University of Berlin, 1993.
52. Baker RL, Norris SA. Clarithromycin prophylaxis against MAC in AIDS [abstr 1193]. In:Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4-7, 1994. Washington, DC:American Society for Microbiology, 1994.
53. Sonnabend JA, Coulston DR, Payne DL. Clarithromycin for Mycobacterium avium complex prophylaxis in patients with AIDS [abstr 1189]. In:Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4-7, 1994. Washington, DC:American Society for Microbiology, 1994.
54. Sinnott JT, Houston SH, Majerus TC, Sanders LI, Bergen G, Ganguly R. Clarithromycin in 500 mg twice/day as prophylaxis for MAC disease - a retrospective study [abstr PB0719]. In:Program and abstracts of the 10th International Conference on AIDS, Yokohama, Japan, August 7-12, 1994. Washington, DC:International AIDS Society/World Health Organization, 1994:176.
55. Nightingale SD, Cameron DW, Gordin FM, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828-33.
56. Abrams DI, Mitchell TF, Child CC, et al. Clofazimine as prophylaxis for disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 1993;167:1459-63.
57. Opravil M, Pechere M, Lazzarin A, et al. Dapsonepyrimethamine (DP) might prevent mycobacteria disease in HIV infection [abstr 1080]. In:Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, October 17-20, 1993. Washington, DC:American Society for Microbiology, 1993.
58. Heifets L, Mor N, Vanderkolk. Mycobacterium avium strains resistant to clarithromycin and azithromycin. Antimicrob Agents Chemother 1993;37(11):2364-70.
59. Heifets LB, Iseman MD. Individualized therapy versus standard regimens in the treatment of Mycobacterium avium infections. Am Rev Respir Dis 1991;144:1-2.
60. Heifets LB, Lindholm-Levy PJ, Comstock RD. Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. Am Rev Respir Dis 1992;145:856-8.